DDX5, in turn, promotes the phosphorylation of mTOR by activating the AKT pathway, so DDX5 exerts its oncogenic function in CRC by mediating the cross-talk between O-GlcNAcylation and AKT/mTOR signaling [65]. This evidence concerns the gene AKT1 and colorectal carcinoma.